Purchase Order W81K0216P0248
- Not listed
- This is a firm fixed price purchase order awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The contract, valued at $95,931.00, is for the delivery of a MiSeq System, a DNA sequencing instrument used for genomic research and diagnostics. While Illumina has previously received prime contract and sub-contract awards from other federal agencies such as the NIH, CDC, USDA, and VA to provide a range of its sequencing...
- This firm fixed-price purchase order contract was awarded by the Medical Command (MEDCOM) of the U.S. Department of Defense to Illumina, Inc., a manufacturer of genomic sequencing systems and analytical tools. The $282,150.00 contract provides for the delivery of a MiSeq diagnostic sequencing system to support research and analysis at the U.S. Army's Fort Detrick facility in Maryland. Illumina has previously provided sequencing platforms and related services to federal agencies including the...
- This is a firm fixed price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The contract, valued at $680,732.58, is for the delivery of a MiSeq FGx Sequencing System, which supports genetic and genomic analysis. The contract has no set-aside designation. Illumina has a history of providing sequencing systems and related goods and services to various federal agencies such as the National...
- This firm fixed-price purchase order contract was awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract has a ceiling value of $75,240.00 and is for the provision of a MiSeq System. The award does not have a set-aside designation. Illumina has previously delivered sequencing systems and services to federal agencies such as the National Institutes of Health, Centers for Disease Control and...
- This is a firm fixed price delivery order awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The $154,828.40 contract is for the purchase of reagents to support MEDCOM's genomic analysis and sequencing capabilities. Illumina has previously received other federal contracts and subcontracts from agencies like the National Institutes of Health, Centers for Disease Control, and Department of Veterans Affairs to provide...
- This is a firm fixed price delivery order contract valued at $242,110.64 awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the provision of Illumina reagents to support the agency's sequencing and genomic analysis needs, without any set-aside designation. Illumina has a history of supporting federal agencies like the NIH, CDC, USDA, and VA with its sequencing systems and related products and...
- This firm fixed-price purchase order, valued at $2,881,079.36, was awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of genetic sequencing products and services. The contract supports genomic sequencing and analysis needs, with Illumina providing a range of sequencing systems, reagents, and bioinformatics products. This award does not have a set-aside designation. Illumina has previously received prime contract and subcontract awards from various federal...
- This is a firm fixed price delivery order contract awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract has a ceiling value of $473,964.67 and is for the provision of various Illumina reagents, with a period of performance through October 28, 2015. This appears to be part of a larger Indefinite Delivery Contract that Illumina holds with the Department of the Navy Bureau of...
- This is a firm fixed price delivery order awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of genomic sequencing and analysis solutions. The $456,023.48 contract provides various reagents and consumables, including TruSeq Cluster Kit V3, PhiX Control V3 Kit, and TruSeq Small RNA Library Prep Kit V2, to support genomic sequencing and analysis capabilities. Illumina has a history of providing sequencing systems, reagents, and services to federal agencies such...
- The U.S. Department of the Army's Medical Command (MEDCOM) awarded a Blanket Purchase Agreement (BPA) call order to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents, for the delivery of a SEQ 100 Sequencing System and associated supplies. The contract, valued at $60,300.26, is a firm fixed price award with no set-aside designation. Illumina has previously received prime and subcontract awards from various federal agencies, including the NIH, CDC, USDA, and VA, to provide...
This is a firm fixed-price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of sequencing and analytical instrumentation and reagents. The contract, valued at $95,931.00, is for the procurement of an SY-410-1003 ASSY, TLA, MISEQ2 item. The contract has no set-aside designation and is intended to support Illumina's provision of sequencing systems, reagents, and services to MEDCOM and its research activities. Illumina has a history of providing sequencing products and solutions to various federal agencies, including the NIH, CDC, USDA, and VA, to enable genomic research and analysis. This award appears to be part of Illumina's existing Indefinite Delivery Contract worth up to $3.3 million with the Department of the Navy Bureau of Medicine and Surgery, which supports the Naval Medical Research Center's biological threat characterization efforts using Illumina's MiSeq, iSeq, NextSeq, and NovaSeq6000 sequencing platforms.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Notice of Intent for Sole Source Award for a Genetic Analyzer | W81K02-16-T-0228 | Department of the Army Medical Command | Award Notice 2/2 | 9/7/16, 1:19 PM | |
Notice of Intent for Sole Source Award for a Genetic Analyzer | W81K02-16-T-0228 | Department of the Army Medical Command | Award Notice 1/2 | 8/22/16, 5:16 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $95.9k | 8/24/16 |